Forest Lexapro Strategy Changes: Reps Encouraging Switches From Celexa
Executive Summary
Forest is restructuring its sales representative compensation program to encourage switches from the company's antidepressant Celexa to the follow-on selective serotonin reuptake inhibitor Lexapro
You may also be interested in...
Forest Namenda Clears FDA; Alzheimer Drug Shipments To Begin In December
Forest is planning a slow roll-out of Namenda (memantine) after a faster-than-expected approval of the Alzheimer's agent
Lexapro Switch Takes New Twist: Forest Launching Celexa Generic In 2005
Forest plans to launch a generic version of its antidepressant Celexa in early 2005
Forest Namenda Clears FDA; Alzheimer Drug Shipments To Begin In December
Forest is planning a slow roll-out of Namenda (memantine) after a faster-than-expected approval of the Alzheimer's agent